Mark Peterson

Denosumab in Postmenopausal Women with Low Bone Mineral Density

Michael R. McClung, E. Michael Lewiecki, Stanley Cohen et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

Jean-Jacques Body, Thierry Façon, Robert E. Coleman et al. · Clinical Cancer Research · 2006 · 491 citations · Full text

Medicine, Oncology, Pharmacology +17

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial

John Primrose, Stephen Falk, Meg Finch-Jones et al. · The Lancet Oncology · 2014 · 433 citations

Medicine, Oncology, Pharmacotherapy +16

Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases

Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa et al. · Journal of Clinical Oncology · 2007 · 386 citations

Medicine, Pharmacology, Pharmacotherapy +17

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 239 citations · Full text

Medicine, Oncology, Pharmacotherapy +17